Together with adopting a healthy lifestyle, Medicines are important pillar in
keeping healthy or getting our health back if we may have been ill. However, we
often know very little about the medicines we use. This section is a guide to the
numerous medicines that are registered in Kenya.
We appreciate your feedback! [Last updated Dec:2011]
Displaying 6631-6640 of 12466 results.
Product Name | Dosage Form | Active Ingredients | Manufacturer Name | Class | |
---|---|---|---|---|---|
INOSERT ? 100 TABLETS | TABLETS | SERTRALINE HYDROCHLORIDE EQUIVALENT TO SERTRALINE 100 MG | IPCA LABORATORIES ; INDIA | PSYCHOTHERAPEUTIC DRUGS | Report Effects |
INOSERT ? 50 TABLETS | TABLETS | SERTRALINE HYDROCHLORIDE EQUIVALENT TO SERTRALINE 50 MG | IPCA LABORATORIES ; INDIA | PSYCHOTHERAPEUTIC DRUGS | Report Effects |
TENORIC - 50 TABLETS | TABLETS | Atenolol Eur. Ph. 50 mg; Chlortalidone Eur. Ph. 12.5 mg | IPCA LABORATORIES ; INDIA | CARDIOVASCULAR DRUGS | Report Effects |
TENORIC TABLETS | TABLETS | Atenolol Eur. Ph. 100 mg; Chlortalidone Eur. Ph. 25 mg | IPCA LABORATORIES ; INDIA | CARDIOVASCULAR DRUGS | Report Effects |
HCQS TABLETS | TABLETS | HYDROXYCHLOROQUINE SULFATE USP 200 MG | IPCA LABORATORIES ; INDIA | ANTI-MALARIALS | Report Effects |
LARIDOX INJECTION (2.5ML) | INJECTION | SULFADOXINE USP 500 MG; PYRIMETHAMINE 25 MG | IPCA LABORATORIES ; INDIA | ANTI-MALARIALS | Report Effects |
LUMERAX TABLETS | TABLETS | ARTEMETHER 20MG; LUMEFANTRINE 120MG | IPCA LABORATORIES ; INDIA | ANTI-MALARIALS | Report Effects |
PRESARTAN-25 TABLETS | TABLETS | Losartan Potassium 25 mg | IPCA LABORATORIES ; INDIA | CARDIOVASCULAR DRUGS | Report Effects |
IPCAVITE-M SYRUP (120ML) | SYRUP | Active Ingredients per 5 mL: Vitamin A USP 3000 IU; Vitamin D3 USP 500 IU; Vitamin B1 BP 2 mg; Riboflavine-5-Phosphate BP 1.2 mg; Nicotinamide BP 10 mg; Vitamin B12 BP 2.5 mg; Vitamin C BP 40 mg; Vitamin B6 BP 1 mg | IPCA LABORATORIES ; INDIA | VITAMIN & MINERALS | Report Effects |
PRESARTAN-50 TABLETS | TABLETS | Losartan Potassium 50 mg | IPCA LABORATORIES ; INDIA | CARDIOVASCULAR DRUGS | Report Effects |